- Design
- Single-centre retrospective cohort with Fine-Gray and Cox models
- Population
- 420 patients with excised high-risk cutaneous squamous cell carcinoma
- Primary outcome
- Recurrence-free and overall survival by preoperative neutrophil-to-lymphocyte ratio
- Effect
- Ratio 3 or more: recurrence-free survival sub-HR 2.43 (95% CI 1.62 to 3.66); overall survival HR 1.49 (1.14 to 1.94)
A single-centre retrospective cohort of 420 patients with high-risk cutaneous squamous cell carcinoma, all excised and with a blood count within 40 days before surgery, tested the neutrophil-to-lymphocyte ratio as a prognostic marker.
The best cut-off was about 3. A ratio of 3 or more was independently associated with recurrence-free survival (sub-hazard ratio 2.43, 95% CI 1.62 to 3.66) and overall survival (hazard ratio 1.49, 1.14 to 1.94), and with other cancer-specific outcomes. Discrimination was modest (AUC 0.622, 0.554 to 0.690).
The authors acknowledge the retrospective single-centre design and possible confounding from unrecorded inflammatory conditions. The cut-off was derived from the same data it was tested in, which tends to overstate performance. The ratio comes from a routine blood count, but it should not drive management by itself.
- A ratio of 3 or more went with a higher recurrence risk (sub-hazard ratio 2.43).
- Discrimination was modest (AUC 0.62), so it cannot sort patients alone.
- The cut-off was chosen in the same cohort, so it needs external validation.
- Concurrent infection or inflammation can raise the ratio.
- Use it, if at all, as one of several risk features alongside histology and staging.
Why it matters
It offers a free preoperative signal where most prognostic factors are only known after excision.
Don't overread it
A retrospective, single-centre study with a cut-off derived in the same cohort shows an association, not a validated decision tool.
The statistics, in plain English
An AUC of 0.62 is only a little better than a coin toss (0.5) at separating patients who recur from those who do not. A hazard ratio can be real and still leave the marker poor at predicting for an individual.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for dermatology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free